Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianling Liu

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
European Heart Journal Open|July 28, 2023
Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy: first-in-human studyXuping Li, Zhaowei Zhu, Jun Liu, et al.
The Journal of International Medical Research|December 16, 2020
Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational studyYanjun Zhong, Lishu Zhao, Guobao Wu, et al.
Frontiers in Immunology|March 6, 2023
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancerChaoyuan Liu, Wei Zhao, Junpeng Xie, et al.
Academic Radiology|October 23, 2016
A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot StudyDrew A Torigian, Judith Green-McKenzie, Xianling Liu, et al.
Journal for Immunotherapy of Cancer|December 10, 2021
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancersChunhong Hu, Lishu Zhao, Wenliang Liu, et al.
BMC Medicine|January 14, 2022
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinomaBiyuan Luo, Fang Ma, Hao Liu, et al.
Cancer Letters|February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibodyJinguan Lin, Song Qu, Kunyu Yang, et al.
The New England Journal of Medicine|October 22, 2025
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial CancerXinan Sheng, Gongqian Zeng, Cuijian Zhang, et al.
Cell Reports. Medicine|October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b studyYuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Journal of Hematology & Oncology|May 9, 2023
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumorsYuanyuan Zhao, Yuxiang Ma, Aimin Zang, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
European Heart Journal Open|July 28, 2023
Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy: first-in-human studyXuping Li, Zhaowei Zhu, Jun Liu, et al.
The Journal of International Medical Research|December 16, 2020
Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational studyYanjun Zhong, Lishu Zhao, Guobao Wu, et al.
Frontiers in Immunology|March 6, 2023
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancerChaoyuan Liu, Wei Zhao, Junpeng Xie, et al.
Academic Radiology|October 23, 2016
A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot StudyDrew A Torigian, Judith Green-McKenzie, Xianling Liu, et al.
Journal for Immunotherapy of Cancer|December 10, 2021
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancersChunhong Hu, Lishu Zhao, Wenliang Liu, et al.
BMC Medicine|January 14, 2022
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinomaBiyuan Luo, Fang Ma, Hao Liu, et al.
Cancer Letters|February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibodyJinguan Lin, Song Qu, Kunyu Yang, et al.
The New England Journal of Medicine|October 22, 2025
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial CancerXinan Sheng, Gongqian Zeng, Cuijian Zhang, et al.
Cell Reports. Medicine|October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b studyYuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Journal of Hematology & Oncology|May 9, 2023
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumorsYuanyuan Zhao, Yuxiang Ma, Aimin Zang, et al.
Pageof 12